» Articles » PMID: 29979859

[In Vivo Study of Chuankezhi Metabolism in Rat]

Overview
Journal Yao Xue Xue Bao
Specialties Pharmacology
Pharmacy
Date 2018 Jul 7
PMID 29979859
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

To study the metabolic products of main compounds of Chuankezhi injection in rat, 12 Sprague Dawley rats were classed into 2 groups, a blank control group and an intermuscular administration group, respectively. Rat feces and urine samples were collected from 0−24 h and 24−48 h after administration. All the samples were ultrasonically treated with methanol and then analyzed using LC-LTQ Orbitrap MSn. By comparison with the total ion chromatogram of samples from the blank control group, the metabolites in the samples of drug-treated group were screened. These metabolites were further analyzed by multistage product ion scanning and comparison of retention time with reference substances. As a result, a total of 12 flavonoid metabolites were tentatively identified from the rat feces and no metabolite was discovered in the rat urine. Epimedin C and icariin were detected in the rat blood samples after 30 min of administration, but their metabolites and other original flavones were not detected. Furthermore, no original flavones and their metabolites were detected in rat blood samples after 2 and 4 h of administration. The potential metabolism paths were further characterized and the principal in vivo transformation of flavones from Chuankezhi injection were deglycosylation, dehydration, methylation, oxidation and isomerization in rats.

Citing Articles

New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action.

Liang R, Yang X, Lin S, Yi W, Chen X, Dong X Ann Transl Med. 2022; 10(11):639.

PMID: 35813313 PMC: 9263774. DOI: 10.21037/atm-22-1962.


Chuankezhi injection for asthma: Protocol of a systematic review and meta-analysis.

Li M, Zheng W, Zhang C, Yan Q, Peng Z, Xie F Medicine (Baltimore). 2019; 98(33):e16630.

PMID: 31415356 PMC: 6831183. DOI: 10.1097/MD.0000000000016630.